|61.35||-0.1700||-0.28%||Vol 15.53K||1Y Perf 180.90%|
|Apr 23rd, 2021 10:00 DELAYED|
|- -%||- -|
|Target Price||57.86||Analyst Rating||Moderate Buy 2.30|
|Potential %||-5.96||Finscreener Ranking||+ 37.87|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||+ 37.95|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||+ 27.49|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Market Cap||5.49B||Earnings Rating||Neutral|
|Price Range Ratio 52W %||96.05||Earnings Date||29th Apr 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||29th Apr 2021|
|Estimated EPS Next Report||0.45|
|EPS Growth Next 5 Years %||12.80|
|Avg. Weekly Volume||411.28K|
|Avg. Monthly Volume||445.06K|
|Avg. Quarterly Volume||594.09K|
Acadia Healthcare Company Inc. (NASDAQ: ACHC) stock closed at 61.52 per share at the end of the most recent trading day (a -1.65% change compared to the prior day closing price) with a volume of 476.75K shares and market capitalization of 5.49B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 42800 people. Acadia Healthcare Company Inc. CEO is Debra K. Osteen.
The one-year performance of Acadia Healthcare Company Inc. stock is 180.9%, while year-to-date (YTD) performance is 22.4%. ACHC stock has a five-year performance of -2.86%. Its 52-week range is between 21.27 and 63, which gives ACHC stock a 52-week price range ratio of 96.05%
Acadia Healthcare Company Inc. currently has a PE ratio of -8.10, a price-to-book (PB) ratio of 2.92, a price-to-sale (PS) ratio of 4.16, a price to cashflow ratio of 8.40, a PEG ratio of 2.32, a ROA of -9.61%, a ROC of 3.80% and a ROE of -29.05%. The company’s profit margin is -57.83%, its EBITDA margin is 20.90%, and its revenue ttm is $1.31 Billion , which makes it $14.62 revenue per share.
Of the last four earnings reports from Acadia Healthcare Company Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.45 for the next earnings report. Acadia Healthcare Company Inc.’s next earnings report date is 29th Apr 2021.
The consensus rating of Wall Street analysts for Acadia Healthcare Company Inc. is Moderate Buy (2.3), with a target price of $57.86, which is -5.96% compared to the current price. The earnings rating for Acadia Healthcare Company Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Acadia Healthcare Company Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Acadia Healthcare Company Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 10.80, ATR14 : 2.21, CCI20 : 139.61, Chaikin Money Flow : 0.08, MACD : 2.37, Money Flow Index : 67.70, ROC : 4.98, RSI : 62.25, STOCH (14,3) : 76.40, STOCH RSI : 0.25, UO : 60.00, Williams %R : -23.60), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Acadia Healthcare Company Inc. in the last 12-months were: Christopher L. Howard (Option Excercise at a value of $382 402), Christopher L. Howard (Sold 33 228 shares of value $1 930 214 ), David Duckworth (Option Excercise at a value of $426 432), David Duckworth (Sold 18 780 shares of value $1 089 991 ), Reeve B. Waud (Sold 354 065 shares of value $12 799 201 ), William F. Grieco (Option Excercise at a value of $33 000), William F. Grieco (Sold 4 000 shares of value $239 340 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.